STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
comments(0)
5-min edit window · permanent after that